Differences in Approaches to Assessment of Safety and Efficacy
Critical efficacy endpoints identified during design of protocol
Generally safety endpoints not know prior to conduct of trial
Adverse events can occur at low frequency
Sophisticated statistical analysis often restricted to evaluation of efficacy
There is a tendency to more crudely combine safety data from multiple trials